Lifeline Scientific Discussion Board http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion http://www.iii.co.uk/icons/logos/uk_logo.gif http://www.iii.co.uk tag:iii.co.uk,2003:tst.9256154 Small-caps:
By David Keohane
http://on.ft.com/yVL7Wi By SpikeyDT ]]> http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=9256154&action=detail Mon, 06 Feb 2012 23:56:00 GMT SpikeyDT tag:iii.co.uk,2003:tst.9115107

.A REALLY SAD BUT TRUE TALE OF A RUGBY PLAYER ON HIS FIRST TRIAL FOR HARLEQUINS..RECEIVING A NECK INJURY THAT TURNS TO CANCER, I HAD TO POST IT ON.

http://www.theshedend.com/topic/19000-a-tragic-tale-of-a-harlequins-rugby-hope-jack-brennan/

Epetheloid Sarcoma..the type that Jack Brennan is suffering from, is currently being treated with 'new' experimental drugs in conjunction with chemo therapy at the Royal Marsden under the care of Prof. Ian Juddson, Britain's foremost oncologist in this sphere.
http://www.ecancermedicalscience.com/tv/most-viewed.asp?play=63&cid=0&scid=0&q=

ValiRx's GeneICE technology has been developed for silencing rebellious genes, which cause conditions such as cancer and various neurological problems. The 'sarcomas' or soft tissue cancers could also be targeted by the drugs being developed by VALiRx

Imperial College, University of London, has been working in collaboration with ValiRx and is currently carrying out the late pre-clinical development of ValiRx's lead therapeutic, VAL101 with funding awarded from the Eurostars scheme. The company announced that stability and toxicology studies are currently underway. The production of the VAL101 compound is going to plan and has been optimised and simplified, which by extension makes the compound cheaper to produce, thereby adding future value.
More on this innovative bio-pharma company....

Hybridan raises target price 3-fold to... 1.66p !
"With a monthly burn-rate of £50,000, we expect the company to be sufficiently funded before an out-licensing deal for one of the lead drug compounds is agreed."
http://www.proactiveinvestors.co.uk/companies/news/37128/ValiRx%20has%20its%20price%20target%20increased%20by%20broker%20Hybridan

proactive news/articles: Everyone a 'positive' update
http://www.proactiveinvestors.co.uk/LON:VAL/ValiRx/

Video-interview-unlimited potential of GeneICE
http://www.proactiveinvestors.co.uk/companies/stocktube/760/satu-vainikka-from-valirx-talks-about-the-unlimited-potential-of-geneice-.html
By dickie3times ]]> http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=9115107&action=detail Mon, 02 Jan 2012 21:29:00 GMT dickie3times tag:iii.co.uk,2003:tst.9115102
From its headquarters in Chicago, Lifeline is focused on developing and manufacturing storage equipment for organ transplantation use. It's first product, the Kidney LifePort, was launched in 2004, having received regulatory clearance in the US in 2003 and in the EU in 2004, and it is now used in some 120 transplant programs in 20 countries. In addition to this, the firm has a portfolio of products for other organs - including the heart, the liver, the lungs and the pancreas - as well as a pharmacological division. Up until recently these projects have been put on a back burner due to cash constraints, but prototypes of these devices are now in pre-clinical trials at medical institutions around the globe, and the liver machine is due to be launched in 2012.

The first half of the year was characterised by increased investment in programmes designed to strengthen Lifeline's product and service offering through product line innovations and the expansion of its geographical reach into emerging markets. "In particular, progress in Brazil is expected to provide additional momentum toward the end of this year into 2012 as the Company is nearing completion of regulatory approvals to enable full market access." Lifeline also sees a huge opportunity opening up in China, which it believes could potentially become the largest volume transplant region in the world within the next 5-10 years. During the period China's equivalent to the US FDA, the State Food and Drug Administration (SFDA), advanced regulatory testing for the firm's full complement of transplant products. Through its partners in China, the company is working with leading regional transplant centres and the China Ministry of Health to arrange a LifePort market demonstration study anticipated to commence 4Q11/1Q12. The company added that it continues to improve its product line while continuing the development of its LifePort Liver Transporter and proprietary machine preservation solution which presently remains on track for launch in 2012.

Investors should also be aware that uptake of LifePort liver could be very rapid indeed upon receipt of regulatory approval, as the firm already has (or is targeting) the requisite network of clients through LifePort kidney. Combined with the rollout in emerging markets, there is a significant medium-term opportunity emerging here, with the shares trading on under 12 times prospective FY12 earnings. Given that the business now enjoys the benefits of a high-margin recurring revenue stream as well as a strong balance sheet (net cash of c.£4.6 million), such a rating looks out of step. Buy, at 176.5p.
By dickie3times ]]> http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=9115102&action=detail Mon, 02 Jan 2012 21:26:00 GMT dickie3times tag:iii.co.uk,2003:tst.9113883 5 Stocks for 2012
Mon, Jan 2, 2012 at 12:07 AM
http://bit.ly/t10Mts By SpikeyDT ]]> http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=9113883&action=detail Mon, 02 Jan 2012 06:27:00 GMT SpikeyDT tag:iii.co.uk,2003:tst.8438273 http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=8438273&action=detail Thu, 23 Jun 2011 14:18:00 GMT lickyricky69 tag:iii.co.uk,2003:tst.8386827 http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=8386827&action=detail Mon, 13 Jun 2011 16:48:00 GMT Somerset_Al tag:iii.co.uk,2003:tst.8262694 http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=8262694&action=detail Tue, 17 May 2011 09:48:00 GMT veester tag:iii.co.uk,2003:tst.8260660 http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=8260660&action=detail Mon, 16 May 2011 20:43:00 GMT AffeMoose tag:iii.co.uk,2003:tst.8248741
Its where i got the tip for this - DoH! Can't believe i didn't make the connection. By veester ]]> http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=8248741&action=detail Fri, 13 May 2011 11:57:00 GMT veester tag:iii.co.uk,2003:tst.8248217 The way TB approached it though indicates it is not something that will happen in perpetuity. By ceeg ]]> http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=8248217&action=detail Fri, 13 May 2011 11:00:00 GMT ceeg tag:iii.co.uk,2003:tst.8248204 RHPS stands for 'Red Hot Penny Shares', it is an investment 'tip sheet' that you can subscribe to, and the author Tom Bulford, provides monthly tips on small cap companies, and some weekly updates. The companies he tips are small cap like I say and tend to be higher risk/ higher reward types.
He doesn't always get it right but personally for me I think it is a great service, and in my experience I have made money overall and I have learned a lot so I am very happy with it.
Just out of interest how did you hear about LSI veester? By ceeg ]]> http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=8248204&action=detail Fri, 13 May 2011 10:59:00 GMT ceeg tag:iii.co.uk,2003:tst.8247768
I'd still like to know what this warrants business is all about. And (more importantly) - will it happen again? By AffeMoose ]]> http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=8247768&action=detail Fri, 13 May 2011 10:10:00 GMT AffeMoose tag:iii.co.uk,2003:tst.8247754
Same company, different share ticker.

LSIC is the common share and can be traded by the US.

LSIC tends to be less liquid in my experience, BUT...the spread is smaller (always) and the price tracks LSI well, but always about 5p more.

Just some advice. By AffeMoose ]]> http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=8247754&action=detail Fri, 13 May 2011 10:09:00 GMT AffeMoose tag:iii.co.uk,2003:tst.8246245 Silly questions was is RHPS?
I bought in 2.40 a while back and its slid since then.
In for the long but just surprised the slip given the solid nature of the company By veester ]]> http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=8246245&action=detail Fri, 13 May 2011 00:16:00 GMT veester tag:iii.co.uk,2003:tst.8246218 http://www.iii.co.uk/investment/detail?code=cotn:LSI.L&display=discussion&id=8246218&action=detail Fri, 13 May 2011 00:06:00 GMT ceeg